Figure 1.
Schematic representation of the cost-effectiveness models.
* If a patient in the post-stroke state had a diagnosis of stable angina, he would remain in the same state, but with a tracker variable signaling the angina diagnosis.
§ The structure of the secondary prevention model was similar, with the exception of the "No previous CVD” Markov state, which was omitted. CV: cardiovascular; CVD: cardiovascular disease; MI: myocardial infarction; SA: stable angina.